LBMPL vaccine therapy induces progressive organization of the spleen microarchitecture, improved Th1 adaptative immune response and control of parasitism in Leishmania infantum naturally infected dogs.

dc.contributor.authorRoatt, Bruno Mendes
dc.contributor.authorCardoso, Jamille Mirelle de Oliveira
dc.contributor.authorReis, Levi Eduardo Soares
dc.contributor.authorMoreira, Gabriel José Lucas
dc.contributor.authorGonçalves, Letícia Captein
dc.contributor.authorMarques, Flávia de Souza
dc.contributor.authorMoreira, Nádia das Dores
dc.contributor.authorVieira, Paula Melo de Abreu
dc.contributor.authorSoares, Rodrigo Dian de Oliveira Aguiar
dc.contributor.authorGiunchetti, Rodolfo Cordeiro
dc.contributor.authorReis, Alexandre Barbosa
dc.date.accessioned2023-10-06T21:02:42Z
dc.date.available2023-10-06T21:02:42Z
dc.date.issued2022pt_BR
dc.description.abstractThe spleen plays a central role in human and canine visceral leishmaniasis, where the activation of the immune response occurs in one of the tissues where Leishmania infantum reproduces. Therefore, this organ is both a target to understand the mechanisms involved in the parasite control and a parameter for assessing the therapeutic response. In this sense, this study aimed to evaluate the main histological, immunological and parasitological aspects in the spleen of symptomatic dogs naturally infected by L. infantum treated with the therapeutic vaccine LBMPL. For this, dogs were divided into four groups: dogs uninfected and untreated (NI group); L. infantum-infected dogs that were not treated (INT group); L. infantum-infected dogs that received treatment only with monophosphoryl lipid A adjuvant (MPL group); and L. infantum-infected dogs that received treatment with the vaccine composed by L. braziliensis promastigote proteins associated with MPL adjuvant (LBMPL group). Ninety days after the therapeutics protocol, the dogs were euthanized and the spleen was collected for the proposed evaluations. Our results demonstrated a reduction of hyperplasia of red pulp and follicular area of white pulp, increased mRNA expression of IFN-γ, TNF-α, IL-12 and iNOS, and decreased IL-10 and TGF-β1, and intense reduction of splenic parasitism in dogs treated with the LBMPL vaccine. These results possibly suggest that the pro-inflammatory environment promoted the progressive organization of the splenic architecture favoring the cellular activation, with consequent parasite control. Along with previously obtained data, our results propose the LBMPL vaccine as a possible treatment strategy for canine visceral leishmaniasis (CVL).pt_BR
dc.identifier.citationROATT, B. M. et al. LBMPL vaccine therapy induces progressive organization of the spleen microarchitecture, improved Th1 adaptative immune response and control of parasitism in leishmania infantum naturally infected dogs. Pathogens, v. 11, n. 9, artigo 974, 2022. Disponível em: <https://www.mdpi.com/2076-0817/11/9/974>. Acesso em: 01 ago. 2023.pt_BR
dc.identifier.doihttps://doi.org/10.3390/pathogens11090974pt_BR
dc.identifier.issn2076-0817
dc.identifier.urihttp://www.repositorio.ufop.br/jspui/handle/123456789/17537
dc.language.isoen_USpt_BR
dc.rightsabertopt_BR
dc.rights.licenseThis article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/). Fonte: PDF do artigo.pt_BR
dc.subjectCanine visceral leishmaniasispt_BR
dc.subjectLeishmania infantumpt_BR
dc.subjectImmunotherapypt_BR
dc.subjectSpleenpt_BR
dc.titleLBMPL vaccine therapy induces progressive organization of the spleen microarchitecture, improved Th1 adaptative immune response and control of parasitism in Leishmania infantum naturally infected dogs.pt_BR
dc.typeArtigo publicado em periodicopt_BR
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
ARTIGO_LBMPLVaccineTherapy.pdf
Tamanho:
1.78 MB
Formato:
Adobe Portable Document Format
Descrição:
Licença do Pacote
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição: